Completed
Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes
NCT04017221
- Conditions
- Acid-Base Imbalance, Acidosis, Diabetes Complications, +10 more
- Locations
-
- Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada